Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Melanoma × Spectroscopy, Near-Infrared × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 82 Nivolumab 50 Ipilimumab 49 Cyclophosphamide 48 fludarabine 24 Vemurafenib 24 Interleukin-2 23 aldesleukin 22 trametinib 19 fludarabine phosphate 18 dabrafenib 15 Biopsy 13 Temozolomide 12 Cisplatin 12 atezolizumab 11 spartalizumab 10 Introns 10 poly ICLC 9 cobimetinib 9 Specimen Handling 9 Radiosurgery 9 MART-1 Antigen 9 Carboplatin 9 incomplete Freund's adjuvant 8 Radiotherapy 8 Radiation 8 Paclitaxel 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 Docetaxel 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01295931 2015-10-07

Nuclear and Near-Infrared (NIR) Imaging in Melanoma

M.D. Anderson Cancer Center

Phase 1 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡